Concise report
Lymphoma in a patient with rheumatoid arthritis receiving
methotrexate treatment: successful treatment with rituximab
M Stewarta, V Malkovskab, J Krishnanc, L Lessinb, W Bartha
a Department of
Rheumatology, Washington Hospital Centre, Washington, DC, USA, b Department of
Haematology-Oncology, Washington Hospital Centre, c Jayashree Krishnan, Department
of Pathology, Washington Hospital Centre
Correspondence to: Dr W F Barth, 2021 K Street, NW, Suite 300, Washington, DC 20006, USA wfbarth{at}worldnet.att.net
Accepted for publication 27 February
2001
A 55 year old man with chronic lymphocytic leukaemia (CLL) and
rheumatoid arthritis (RA), treated for four years with methotrexate (MTX), who developed a B cell non-Hodgkin's lymphoma (B-NHL), is
described. The tumour was localised to the shoulder and axillary lymph
nodes, and positive for Epstein-Barr viral antigens. After failure of
radiation and chemotherapy, a complete remission was achieved with a
combination of antibody treatment (rituximab) and EPOCH. The
development of a second malignancy in a patient with RA receiving MTX
has not been described before. The summation of T cell deficiencies
induced by MTX, CLL, and RA may all have contributed to the development
of the B-NHL.
© 2001 by Annals of the Rheumatic Diseases
This article has been cited by other articles:
-
Wiestner, A., Cho, H. J., Asch, A. S., Michelis, M. A., Zeller, J. A., Peerschke, E. I. B., Weksler, B. B., Schechter, G. P.
(2002). Rituximab in the treatment of acquired factor VIII inhibitors. Blood
100: 3426-3428
[Abstract] [Full Text]
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
